Lovastatin Enhances Chemosensitivity of Paclitaxel-Resistant Prostate Cancer Cells Through Inhibition of CYP2C8.
Biochemical and biophysical research communications(2022)
Key words
Prostate cancer,Lovastatin,Paclitaxel,Drug sensitivity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined